PIA
AMPE

Piedmont Investment Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Piedmont Investment Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5
Closed -$3K – 2542
2018
Q2 		$3K Buy
+5
New +$3.74K ﹤0.01% 2471

Other funds holding AMPE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Piedmont Investment Advisors's AMPE Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2018, closing a stake of 5 shares — an estimated $3K sold.

Piedmont Investment Advisors first reported a position in AMPE in Q2 2018 and held it in 1 quarter. The position peaked at $3K in Q2 2018. 81 funds tracked by Wall St. Rank hold AMPE as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 5 Ampio Pharmaceuticals Inc. shares in Q3 2018, an estimated $3K.
  • Piedmont Investment Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Ampio Pharmaceuticals Inc. position peaked at $3K in Q2 2018.
  • 81 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.